Lessons from large interventional trials on antihypertensive therapy in chronic renal disease

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 11, 2002, Pages 47-49

  Maschio, Giuseppe ^a   Marcantoni, Carmelita ^b   Bernich, Patrizia ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b CANNIZZARO HOSPITAL   (Italy)

Author keywords

ACE inhibitors; Anaemia; Chronic kidney disease; Hypertension; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CREATININE; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; FOSINOPRIL; NIFEDIPINE; PLACEBO; RAMIPRIL;

AGE; ANALYTICAL PARAMETERS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG EFFICACY; GENDER; HUMAN; HYPERTENSION; KIDNEY FUNCTION; META ANALYSIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEINURIA; RACE; RISK FACTOR;

EID: 0036411899     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_11.47     Document Type: Article

References (8)

1. Klahr S, Levey AS, Beek GJ et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-884
2. Zucchelli P, Zuccalà A, Borghi M et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-458
3. Maschio G, Alberti D, Janin G et al. Effect of angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945
4. Randomized, placebo-controlled trial of effect of raimpril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863
5. Jafar TH, Schmid CH, Landa M et al. Angiotensin-converting-enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73-87
6. Cinotti GA, Zucchelli PC. Collaborative Study Group. Effect of lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant 2001; 16: 961-966
7. Marin R, Ruilope LM, Alijama P, Aranda P, Segura J, Diez J. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease. J Hypertens 2001; 19: 1871-1876
8. Herlitz H, Harris K, Risler T et al. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. Nephrol Dial Transplant 2001; 16: 2158-2165